ACHYUT Stock View

Achyut Healthcare Ltd

ACHYUT Stock View

(BSE)

Trade

2.00 | 3.64

Market Cap ₹( Cr.)
799.00

Proj. P/E (x)

Proj. P/BV (x)

Proj. ROE (%)

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)

Last Updated On.
24-Sep-2023

 

Copy Link

Achyut Healthcare Limited is an India-based company, which is engaged in the trading of pharmaceutical business. The Company operates in the single business segment of manufacturing pharmaceutical formulations in the forms of tablets, capsules, oral liquids, and injectables. It is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The Company is engaged in the trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium Carbonate Oyster, Cellulose Acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, among many other products. The Company is in the trading business in both domestic as well as international markets in the countries of the United Arab Emirates (UAE), Kenya, and Nigeria.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data